A major research question in multiple sclerosis (MS) is to determine if a person with MS is progressing in their disease course and how they are responding to treatments? Researchers attending the American Academy of Neurology(AAN) meeting addressed this crucial question by looking at a new emerging biomarker for MS. Biomarkers are signatures found in the body that can be objectively measured and can be an indicator of your health or reveal the presence or progress of a disease. Continue reading
An intense week of latest and hottest research news and updates are awaiting the research team at the 70th American Academy Neurology (AAN) annual meeting that will take place in sunny Los Angeles from April 21 to April 28. This is the largest meeting of its kind, with over 10,000 people attending including neurologist and researchers from all over the world gathering to present and discuss their recent discoveries, cutting-edge developments and advancements. This diverse meeting focuses on many areas in neurology including multiple sclerosis, dementia, epilepsy, and other neurological conditions. Educational programs are also offered to clinicians to test their knowledge and stay up to date on the best clinical practices for disease treatment and management.
Several posters and presentations from the leading MS researchers and clinicians will keep the research team buzzing around to capture and report as much information as possible. We are excited to learn about biomarkers, risk factors for MS, treatment outcomes in clinical research, and pediatric MS, just to name a few!
Want to find out about what we learn at the conference? Check out our #AAN2018 #AANAM updates next week, both here on the blog and on Twitter at @Dr_KarenLee.